Balentine LLC’s Exponent EXPO Stock Holding History

Balentine LLC’s Portfolio EXPO Stock Details EXPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-46	Closed	-$3K	–	763
2019 Q2	$3K	Buy	+46	New	+$2.62K	﹤0.01%	587

Other funds holding EXPO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Balentine LLC's EXPO Position: Q3 2019 in Review

Balentine LLC sold out of Exponent (EXPO) in Q3 2019, closing a stake of 46 shares — an estimated $3K sold.

Balentine LLC first reported a position in EXPO in Q2 2019 and held it in 1 quarter. The position peaked at $3K in Q2 2019. 275 funds tracked by Wall St. Rank hold EXPO as of Q3 2019.

Balentine LLC reported no remaining Exponent position as of Q3 2019 after selling out during the quarter.
Balentine LLC sold 46 Exponent shares in Q3 2019, an estimated $3K.
Balentine LLC first reported a position in Exponent in Q2 2019 and held it in 1 quarter.
Balentine LLC's Exponent position peaked at $3K in Q2 2019.
275 funds tracked by Wall St. Rank held Exponent as of Q3 2019.

Based on Balentine LLC's 13F filing for Q3 2019, filed 15 Nov 2019.